Skip to comments.Attention Prayer Warriors - Lightman's wife had a TIA
Posted on 11/14/2011 5:30:23 PM PST by RebelBanker
Lightman's wife Jan suffered a TIA ("mini-stroke") during church service Sunday. She was taken to the hospital for tests and seems to have recovered functionality, but is still suffering from weakness on her right side.
Please offer up whatever prayers you can for Jan, lightman and their family!
Prayers for a complete healing
If the person can get to the hospital pretty quickly and get the right drugs they can fully recover from a TIA.
Sorry if this ping list is a bit old. Please ping the rest of the prayer warriors - a FReeper and his family are in need.
God bless you and thank you!
Prayers for Jan.
Prayers going up!
Prayers up for Jan, and all my fellow FReepers.
Prayers going up!!
Prayers for her health.
Continuing prayers for Jan!
I prayed for her in my Morning Prayer, and will continue to do so until she is completely healed.
Prayers up! My Dad suffered a couple of TIAs in his later years; they can be quite serious. May God restore her to full health and keep her safe!
Prayers continuing for Jan. And for you.
Friends father had one a year ago. They are very treatable.
Joining in prayer for Jan’s complete healing and comfort for lightman. In Jesus’ name we pray. Amen.
Prayers for Jan’s full recovery.
I’ll add Jan to our Parish’s Prayer list this week, for full healing.
Prayers for Jan, though I don’t know her, because The LORD does and loves her.
Stroke Since 1972, in studies of stroke in three animal models (dog, rat, gerbil) ubiquinone was the only agent giving complete protection and this was over two times more often than the next best agent (naloxone) of the many tested to date. Some of the animals were pretreated and some post-stroke (less than 12 hrs). None of the 50+ synthetic stroke agents tested in humans has yet proven successful as of February 2000. If mainstream medicine has any humanistic motivation, why doesn't it use ubiquinone in the interim? The first human observation using ubiquinone was in a patient predicted by the very experienced stroke specialists in a large California facility to remain permanently comatose. But, she recovered completely after about 10 days in coma. She had been in treatment for a memory problem with oral ubiquinone 400 mg/day for a month prior to an accidental head trauma with massive hemorrhage. In a second case (unpublished), a woman in her 60's, the mother of Dr Fudenberg's former secretary, had a similar stroke with the same prognosis of permanently vegetative; he traveled from South Carolina to Oklahoma, got the patient out of hospital and gave her 400 mg ubiquinone b.i.d. (starting four days post-stroke, which we felt would be too late) and she recovered to much better than her pre-stroke condition (i.e., mental acuity, speech, agility, equal to what she had experienced in her 40's). There has been a third case which we "do not advertise" because it is extremely important to elevate ubiquinone as rapidly as possible to minimize the ischemic reperfusion injury. This is a 70 year old male professional dancer in Seattle who was given ubiquinone in similar oral dosing starting on the 11th day and made progress much above predicted; he regained speech and ability to do dance steps but had difficulty with names and his recovery plateaued after a few weeks; his stroke was not comatose and his recovery was not complete to his pre-stroke condition. Can't the medical (and lay) readers of this journal help stimulate a grass-roots evaluation of this simple innocuous treatment? We emphasize that we are not advising people to self-treat. However, everyone must realize that, each year in the U.S. alone, over 650,000 families have a loved one hospitalized for stroke. Only 1/4 of these escape death or permanent disability. The families have a right to know that ubiquinone exists at their health food stores, has the properties described above and appears likely to avert the tragic prognoses. If you readers pass this information to such families, many, in their desperation, may elect ubiquinone. We request the readers suggest: (1) this be done with the best open-minded preventive medicine supervision available; and (2) the supervising physician report by email (firstname.lastname@example.org) the patient identification, date of stroke, treating stroke center, prognosis, time delay before ubiquinone (swallowed or intubation), dosage including other agents, and progress up to 4 weeks post-stroke.
Payers sent for Jan.
Prayers for all are on the way.
Thank you all so, so much!
Jan was discharged from the hospital at 12:30 Tuesday. She is not to return to teaching until after the Thanksgiving break.
The diagnosis is inconclusive, most likely a complex migraine or “hemipalegic migraine”/ She has had migraines for years, but never any that behaved in this fashion. So the treatment is for migraines simultaneous with working on stroke prevention.
Thanks be to God—and thanks to all you who besought Him in prayer.